Mark Onwuji
About Mark Onwuji
Mark Onwuji is the Associate Director of Translational Medicine PMO - Solid Tumor Oncology at Bristol Myers Squibb, with over 15 years of experience in the medical and pharmaceutical industries.
Company
Mark Onwuji currently works at Bristol Myers Squibb as the Associate Director of Translational Medicine PMO, focusing on Solid Tumor Oncology in the Greater New York City Area.
Title
Associate Director, Translational Medicine PMO - Solid Tumor Oncology, Greater New York City Area.
Education and Expertise
Mark Onwuji has a diverse educational background. He holds a Master of Business Administration (MBA) from Penn State University. He also earned a Master of Science (M.S) in Manufacturing Systems and a Bachelor of Science (B.S) in Mechanical Engineering from the University of St. Thomas. Additionally, he completed a program in Product Strategy at Kellogg Executive Education.
Background
Mark Onwuji has over 15 years of experience in the medical and pharmaceutical industries. He has held leadership roles in project management and product development at multiple top-tier pharmaceutical companies, including Regeneron, BD, and Johnson & Johnson. His career has spanned various roles such as Staff Device Development Engineer and Program Manager.
Achievements
Mark Onwuji has significant expertise in the field of oncology, particularly in solid tumors. He has been involved in the development of personalized treatments and cutting-edge research. His work utilizes data analytics to enhance the precision of therapeutic interventions. He is committed to improving health outcomes for populations disproportionately affected by serious diseases.